Publisher： Karger
E-ISSN： 2296-5262|39|1-2|9-16
ISSN： 2296-5270
Source： Oncology Research and Treatment, Vol.39, Iss.1-2, 2016-0, pp. : 9-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Pathogenesis, Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Exciting Times
Oncology Research and Treatment, Vol. 39, Iss. 1-2, 2016-0 ,pp. :
Genomic Features: Impact on Pathogenesis and Treatment of Chronic Lymphocytic Leukemia
Oncology Research and Treatment, Vol. 39, Iss. 1-2, 2016-0 ,pp. :
Ofatumumab for the treatment of chronic lymphocytic leukemia
Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. :
Histone Deacetylase in Chronic Lymphocytic Leukemia
Oncology, Vol. 81, Iss. 5-6, 2012-01 ,pp. :